To elucidate the role of growth hormone (GH)-releasing hormone (GRH) and somatostatin (SRIH) in the regulation of the growth hormone (GH) secretory pattern, we collected portal blood from five unanesthetized ovariectomized ewes for repeated measurements of GRH and SRIH simultaneous with those of peripheral GH. Hormones were measured at 10-min intervals for 5.5 h and their interrelationships analyzed. Mean portal GRH was 20.4±6.7 (SD) pg/ml and the estimated overall secretion rate was 13 pg/min. GRH secretion was pulsatile with peaks of 25-40 pg/ml and a mean pulse interval of 71 min. Mean portal SRIH was 72±33 pg/ml and the estimated overall secretion rate was 32 pg/min. SRIH secretion was also pulsatile with peaks of 65-160 pg/ml and a mean pulse interval of 54 min. The GH pulse interval was 62 min. A significant association was present between GRH and GH secretory peaks though not between GRH and SRIH or SRIH and GH. Insulin hypoglycemia resulted in a rapid and brief stimulation of SRIH secretion followed by a decline in GH levels. No effect was observed on GRH secretion until 90 min, when a slight increase occurred. The results suggest (a) the presence of an independent neural rhythmicity of GRH and SRIH secretion with a primary role of GRH in determining pulsatile GRH secretion, and (b) that the inhibitory effects of insulin hypoglycemia on GH in this species are attributable to a combination of enhanced SRIH secretion and possibly other factors, though without significant inhibition of GRH. (J. Clin. Invest. 1990. 86:17-24 approach the sensitivity of detection by current techniques (1). The neuroendocrine mechanism that regulates GH secretion is mediated by two hypothalamic hormones, one of which is stimulatory (GH-releasing hormone [GRH]) and the other, inhibitory (somatostatin [SRIH]). Although their effects on GH secretion have been studied extensively, there have been formidable technical difficulties in obtaining simultaneous measurements of the two neurohormones in hypothalamichypophysial portal blood and comparing their secretory patterns with those of GH in peripheral blood under physiologic conditions. Thus, the pattern of their release from the median eminence into the hypothalamic-hypophysial portal system and current knowledge of their precise interaction in regulating pulsatile GH secretion is based almost entirely on indirect evidence. Initial results of passive immunization with anti-GRH serum (2) and anti-SRIH serum (3) suggested that pulsatile GH secretion was dependent on pulses of GRH and that the role of SRIH was primarily to set the level of the GH responses to GRH. However, subsequent studies with infusions of anti-SRIH serum (4), comparison of GH responses to GRH during trough and pulse periods ofGH secretion (5), and interruption of intrahypothalamic somatostatinergic neuronal circuitry (6) suggested the presence of intermittent and possibly pulsatile secretion of SRIH as well as GRH.
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Attempts to measure GRH and SRIH in peripheral circulation have not clarified their hypophysiotropic roles since (a) SRIH immunoreactivity is believed attributable to gastro-pancreatic rather than hypothalamic origin (7) , and (b) GRH immunoreactivity remains to be critically characterized and may also be of nonhypothalamic origin (8) . One study has reported repeated measurements of immunoreactive GRH and SRIH in portal blood of rats and demonstrated a slight decrease in SRIH levels during a 20-min period before a rise in GRH levels was observed (9). However, the use of anesthetized animals and the necessity of hypophysectomy in order to collect portal blood limited the overall interpretation of these results.
Recently, a technique has become available for repeated sampling of hypothalamic-hypophysial portal blood in unanesthetized sheep and has been used successfully in demonstrating a high degree of concordance between pulsatile secretion of gonadotropin-releasing hormone and luteinizing hormone (10, 1 1) . In the present report, we describe the use ofthis model to examine the interaction of hypothalamic GRH and SRIH secretion in the regulation ofGH under basal conditions and in response to insulin-induced hypoglycemia.
Methods

Animals and experimental techniques
Studies were performed in five mature Corriedale ewes (38-44 kg) that had been ovariectomized for at least 3 mo before portal blood collection. During experiments, the sheep were housed in individual pens under natural photoperiodic conditions and given a maintenance ra-tion of lucerne chaff and grain with free access to water. The sheep were prepared for portal blood collection as previously described (10, 11) . Briefly, under halothane anesthesia, a tunnel was drilled into the sphenoid bone from the back of the nasal cavity to create an artificial sinus immediately anterior to the pituitary gland. Two 12-G needles were implanted through the nasal bone so that one was directed at the portal vessels on the face of the gland, and the other opened into the floor ofthe artificial sinus. The artificial sinus was then sealed offfrom the nose with dental acrylic and the animal allowed to recover. 24 h later, a catheter was placed in the external jugular vein for collection of peripheral blood and the animal was heparinized. A 16-G stilette was then passed through the upper needle and used to puncture the portal veins to a depth of 2-3 mm on the anterior surface of the pituitary. Based on previous experience, -50% of the portal vessels are transected by this procedure. Extreme care is taken when positioning the needles to avoid cutting too far laterally and damaging the cavernous sinus. The needle position and extent of transection were verified at autopsy in each animal. Portal blood was withdrawn from the artificial sinus by constant suction applied to a catheter in the lower needle. Blood was collected at 10-(or occasionally 5-) min intervals into tubes containing aprotinin (500 KIU/ml blood) and immediately chilled. The volume of each portal blood sample was -3.0 ml and was fairly constant, varying by only -20% throughout the experimental period. Bacitracin, used as a peptidase inhibitor in previous experiments (10), was omitted after preliminary studies indicated interference in the GRH RIA. A sample ofjugular blood (5.0 ml) was obtained every 5 or 10 min, immediately after the end ofeach portal collection period. On the basis of previous studies ( 12) , the contribution of retrograde pituitary blood flow to the diverted portal blood is believed to be minimal. Observation of the animals did not indicate any evidence of stress during the sampling period except that due to handling at the beginning of the experiment.
After a 5-h blood sampling period, regular insulin (Commonwealth Serum Laboratories, Melbourne; 5 U/kg) was injected intravenously and portal and peripheral blood samples collected for an additional 2 h. Previous studies have shown this dose ofinsulin to reliably lower the mean plasma glucose levels within 40 min to -20 mg/dl (13) . Total blood removal during the entire study was -320 ml, which represented 8% of blood volume. Hematocrit determinations, performed at 2-3-h intervals, revealed no significant change during the study period. Blood samples were centrifuged at 4VC and the plasma stored at -20'C until transported from Melbourne to Cincinnati on dry ice.
Plasma extraction and hormone assays
In preliminary experiments, ovine plasma was acidified with 0.2 ml 1.0 M trifluoroacetic acid (TFA)/ml plasma and extracted on a reverse phase C18 Sep-Pak (Waters Associates, Milford, MA) as previously described (14) . Retained substances were eluted with 2 ml 80% acetonitrile/20% 0.01 M TFA and the eluate was Iyophilized. Initially SRIH recovery remained at > 90%k, while hGRH and oGRH recovery decreased to 10-20% (hGRH and oGRH recovery from human plasma using identical conditions remained at > 90% and 80-85%, respectively). The final recovery of oGRH or hGRH from the ovine plasma extract was increased to a maximum of 65-70% by resuspending the Iyophilisate in 5 mM acetic acid, 0.25% BSA, 0.01%
Tween-20 (ABT).
A l-ml aliquot of portal and jugular plasma from each animal at each time point was extracted as a group, together with three l-ml aliquots of an ovine jugular plasma pool with added oGRH and SRIH to monitor recovery. The extracts were 1yophilized, resuspended in 0.3 ml ABT, centrifuged (10,000 g, 10 min 4C), and the supernatants assayed in duplicate for oGRH and SRIH (100-and 25-Ml aliquots, respectively). The recovery ofSRIH and oGRH from the plasma pools was 95±2% and 66±2% (mean±SE, n = 5 each), respectively. Results were not corrected for recovery.
Plasma oGRH was measured by a modification of the previously described RIA for hGRH (14) , using anti-hGRH( -40)-OH antiserum (No. 871), [125I]hGRH(l-40)-OH tracer, and an oGRH standard (Peninsula Laboratories, Inc., Belmont, CA). The crossreactivity of oGRH was 80% compared with the hGRH(I-40)-OH standard with parallel displacement. All portal and jugular samples from each animal were measured in a single assay. The intra-and interassay coefficients of variation (CVs) were 12.5 and 10.6%, respectively, and the average sensitivity ofthe assay was 2.7 pg/tube (9 pg/ml plasma). Plasma SRIH was measured by RIA, as previously reported (15, 16), with portal and jugular samples from each animal measured in a single assay. The average sensitivity was 1.5 pg/tube (5 pg/ml plasma), with intra-and interassay CVs of 7.1 and 11.2%, respectively. The dilution curves of immunoreactive (IR) oGRH and SRIH in portal plasma were parallel to those of synthetic oGRH and hGRH and SRIH, respectively. Ovine GH was measured by RIA using the reagents provided by the National Hormone Pituitary Program (Baltimore, MD). All jugular samples were measured in duplicate with an intraassay CV of 10.4%. The average sensitivity was 25 pg/tube (500 pg/ml plasma) based on the National Institute ofArthritis, Diabetes, and Digestive and Kidney Diseases oGH-I-4 reference standard. For purposes ofstatistical analysis (see below) the least detectable value for the particular assay was assigned to all values that were at or beneath that level. Blood glucose was measured by a glucose oxidase method.
Statistical analysis
Comparison of spontaneous secretory patterns of GRH, SRIH, and GH. We initially determined whether directional changes in GRH (concordant) and/or SRIH (discordant) occurred immediately before (i.e. in the preceding sample) or simultaneous with changes in GH or the other hypothalamic hormone. A computer program was developed to tabulate the frequency ofsuch changes between pairs ofhormones in each individual animal during the 5-h period when spontaneous secretion was monitored. Multiple criteria for change were examined, ranging from 0 to 10 pg/ml (GRH or SRIH) and 0 to 3 ng/ml (GH) (absolute) and 0 to 200% (relative). The resulting frequencies (expressed as a percentage) in the five animals ("experimental") were then compared with that expected by random association and generated by comparing directional changes in hormone values from different animals ("random") rather than the same animal. Thus, four separate sets of random frequencies were available for each animal, giving a total of 20 random series with which to compare the results in the five individual animals. Differences between the two groups were determined by Student's t test.
The pulses present in each hormone secretory profile during the 5-h spontaneous secretion period were determined by the program Detect (17) (method 1). The frequency with which pulses of GRH or SRIH occurred immediately preceding or concurrently with those of GH or of one another in individual animals was compared with the random frequency observed using pairs of animals as described above. Statistical differences in frequency were determined by the chi square test. As a validation ofthe appropriateness ofthe Detect algorithm, pulses were also determined, using as criteria, an increase ofat least three times the CV greater than the preceding minimum trough value. The trough minimum was defined as the lowest value in a series of hormone measurements beginning with a decreasing value and including all subsequent values that (a) were no greater than three times the CV of the lowest included value and (b) did not initiate a progressive rise that culminated in a level at least three times the CV ofthe lowest included value (method 2).
Insulin-induced hypoglycemia. Mean GRH, SRIH, and GH values after insulin administration were compared by a repeated measures analysis of variance. A P < 0.05 was considered significant.
Results
Recovery of immunoreactive GRH from ovine portal plasma. The recovery of '251-labeled oGRH from either ovine or human plasma was always consistently lower (10-15%) than that of [1251I] hGRH. This appeared to be primarily the result of a slightly reduced elution efficiency for oGRH from the SepPak cartridge and occurred in the presence or absence of plasma. The major problem encountered was with the recovery of GRH from lyophilized ovine plasma extracts. RIA of ovine plasma extracts containing added unlabeled oGRH or hGRH, after resuspension in RIA buffer, revealed that only 10-20% ofthe added peptide was measurable, while the recovery of these peptides from human plasma using identical conditions was the same as that seen with ['251]oGRH (80-85%) and ['25I]hGRH (> 90%). Resuspension of the lyophilized ovine plasma extract in an acidic solution (pH < 5) or at low salt concentration increased the recovery of GRH from ovine portal or jugular plasma to a maximail level of 65-70%. Whether this effect is due to the presence ofa substance(s) with specific or nonspecific binding affinity for GRH is unknown. However, the same difficulties have been encountered with the recovery of GRH from bovine plasma extracts (data not shown), while GRH recovery from human, porcine, and murine plasma extracts by our standard protocol has been very efficient (> 90%).
Jugular venous samples were also assayed for oGRH and SRIH in all five sheep. Of a total of 135 samples, IR-oGRH was detected in 26 (19%), though in all samples, values were < 30 pg/ml and generally less than double the least detectable value for the particular assay. These barely detectable values were insufficient for further characterization. SRIH was detected in 121 (82%) of 147 jugular plasma samples. Values were almost always less than half ofthose in portal plasma and exhibited an overall mean±SD of 21 ± 13 pg/ml. Spontaneous secretory pattern ofportal GRH and SRIH and of peripheral GH. The secretory patterns of GRH and SRIH in portal plasma and ofGH in jugular plasma during the 5-h observation period for each of the animals are shown in Fig. 1 . IR-GRH was detectable in all ofthe samples from three sheep and in 87 and 58% of samples from the other two animals. Overall mean portal GRH was 20.4±6.7 pg/ml (mean±SD). On the basis of a 0.3-ml/min blood collection, a hematocrit of 29.0±2.2%, an extraction efficiency of 66%, and assuming a 50% removal of portal blood by the surgical technique (resulting in a corrected portal blood flow of 0.6 ml/ min), the mean hypothalamic secretory rate of GRH was calculated to be 13.2 pg/min.
GRH secretion was pulsatile in each of the animals with peak values ranging from 25 to 40 pg/ml. The number of pulses detected during the 5-h period (method 1) ranged from 3 to 6 with a mean of 4.2±1.1, representing a mean pulse interval of 71 min. An identical number of pulses (4.2±1.3) were detected using method 2.
SRIH was detectable in all ofthe portal samples from each ofthe sheep. Overall mean portal SRIH was 72±33 pg/ml and the mean hypothalamic secretory rate of SRIH was calculated (as above) to be 32.3 pg/min. SRIH secretion was pulsatile in each of the animals, with peak values ranging from 65 to 160 pg/ml. The number of pulses detected during the 5-h period (method 1) ranged from 4 to 9 with a mean of 5.6±2.1, representing a mean pulse interval of 54 min. Using method 2, 5.8±1.9 pulses were detected, representing a mean pulse interval of 52 min.
Plasma GH levels were detectable in 97% of the jugular samples. Overall mean jugular plasma GH was 2.9±2.2 ng/ml. GH secretion exhibited pulsatility in each of the sheep, with peak values ranging from 4 to 11 ng/ml. Using method 1, the mean number ofGH pulses during the 5-h period was 4.6+2.2, representing a mean pulse interval of 65 min, whereas with method 2, the values were 5.2±1.6 pulses and 58 min, respectively.
Relationships among GRH, SRIH, and GH levels. Using the algorithm described for comparing directional changes in GRH, SRIH, and GH levels, we found that a substantial percentage of concordance in directional changes between GRH and GH and discordance in directional changes between SRIH and GH when examined at simultaneous time periods or with a one sample lag time for the GH value (Fig. 2) . However, when these percentages were compared with those that would be expected randomly (by analyzing hormone values from different animals), there were no significant differences. The curves of the random comparisons were virtually superimposable on those derived from the intra-animal comparisons in the five sheep. Subsequent analyses therefore used GRH, SRIH, and GH peaks and SRIH troughs as determined by methods 1 and 2.
Using hormone peaks as defined by method 1, we determined the percentage of GH peaks occurring coincident with or immediately after (one sample) those ofGRH or SRIH and also the interrelationship ofGRH and SRIH peaks. The results are shown in Table I . 38% of the GH peaks occurred coincident with GRH peaks and 62% occurred either coincident with or immediately (one sample later) after GRH peaks. These associations were statistically significant when compared with random associations from different animals (P < 0.05 and P < 0.02, respectively) or to associations with SRIH peaks (P < 0.02 and P < 0.01, respectively). In contrast, GH peaks coincident with SRIH peaks were not significantly different between experimental and random pairings. Similarly, the frequency of GRH peaks immediately preceding SRIH peaks or SRIH peaks immediately preceding GRH peaks did not differ significantly between experimental and random pairings.
The results ofanalyses using peaks defined by method 2 are shown in Table II . The association of GRH and GH peaks was qualitatively similar to that obtained with method 1 (data not shown). GRH peaks were found to occur coincident with (28%, P = 0.025) or immediately preceding (48%, P < 0.01) the initiation ofthe GH peak. There was no association ofGH peak initiation with SRIH troughs.
Effect ofinsulin-induced hypoglycemia on portal GRH and SRIH and jugular GH levels. The results of insulin-induced hypoglycemia are shown in Fig. 3 [17] ) has been validated in studies using peripheral blood measurements and the other of which was developed specifically for these studies. The comparability of the pulse analyses by the two methods helps support the conclusion that the results are not technique dependent. The absence of any recirculation of GRH in the portal vascular system actually simplifies the interpretation of the results since hormone metabolic clearance (i.e., half life) need not be considered. SRIH secretion was also shown to be pulsatile with a pulse interval of 52-54 min. As with GRH, the two analytic techniques used to determine pulse frequency gave comparable results. Although the SRIH frequency was slightly faster than that ofGRH, the small number ofanimals studied, the limited time period (5 h) of each study, and the interanimal variability does not permit a statistical distinction between the pulse frequencies of the two hormones.
GH secretion, as reflected by measurements in jugular plasma, was also pulsatile with a frequency of one pulse every 58-65 min, intermediate between that of GRH and SRIH. An initial elevation of GH values seen in two of the sheep is believed to reflect a stress response before initiation of sample collection.
The analysis of the interaction between GRH and SRIH also required a novel analytic approach and we initially attempted to compare directional changes in individual hormone concentrations. Although considerable concordance (GRH vs. GH) and discordance (SRIH vs. GH) were found, these values were not statistically distinguishable from those expected on the basis of chance observations alone. When the same analysis was applied to the hormone secretory peaks rather than the individual values, however, a highly significant association was seen between peaks of GRH simultaneous with or immediately preceding both GH peaks and initiation of the GH pulse. This association could explain the majority (62%) of the GH peaks observed. In contrast, no such association was observed between SRIH troughs and GH peaks or between GRH and SRIH peaks in portal plasma. These findings provide evidence in the pulsatile secretory pattern of4 of an observed association betwee pulses suggests that SRIH exerts a tiating GH pulses. However, the pc tensity of the GH pulse (i.e., pulse 1 an extent modified by the level of GRH pulse. Attempts to demonsti the present study were, however, ui of the small number of pulses in i] interanimal variability in hormone plete coupling of either GRH or S raises the possibility of yet another contributes to GH pulsatility. The factor, however, remains unknown. (20) , may have affected the release of another, yet unidentified factor that influences GH secretion. Finally, our results in the sheep (as in the rat) are in marked contrast to those in humans where insulin-induced hypoglycemia increases circulating GH concentrations (25) and indirect evidence exists for the suppression ofSRIH secretion, based on the enhancement by insulin of the GH response to GRH (26) . The explanation for this species difference remains unknown.
In summary, the present studies have described pulsatile patterns of GRH and SRIH in hypothalamic-pituitary portal 
